CIK 0001386570
- Large accelerated filer
Niagen Bioscience, Inc.
Sign in to watch- Ticker
- NAGE
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262940963
- Phone
- +1 310-388-6706
- Business address
- 10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
- 4/A Open-market buy PRESIDENT, COO bought 10,000 shares at $3.63 ($36,300)
- 4 Grant or award PRESIDENT, COO acquired 10,000 shares (grant or award)
- 4 Open-market sale CEO sold 474 shares at $4.60 ($2,180)
- 4 Open-market sale CEO sold 24,578 shares at $4.60 ($113,059)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO sold 28,379 shares at an average $6.52 ($184,906)
- 4 Open-market sale CEO sold 58,400 shares at $6.19 ($361,496)
- 4 Grant or award PRESIDENT, CHIEF STRATEGY OFF. acquired 333,333 shares (grant or award)
- 4 Open-market buy 10% owner bought 731,707 shares at $4.10 ($2,999,999)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 2,000 shares at $3.31 ($6,620)
- 4 Open-market buy 10% owner bought 1,179,250 shares at $2.60 ($3,066,050)
- 4 Open-market buy 10% owner bought 786,167 shares at $2.60 ($2,044,034)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 20 · 384 filings